Mechanisms, treatment and prevention of cellular injury and death from delayed events after aneurysmal subarachnoid hemorrhage

Expert Opin Pharmacother. 2014 Feb;15(2):231-43. doi: 10.1517/14656566.2014.865724. Epub 2013 Nov 27.

Abstract

Introduction: Subarachnoid hemorrhage (SAH) patients often develop brain injury as a result of a number of delayed complications, resulting in significant morbidity and mortality. Many of these complications arise due to delayed cerebral ischemia, which occurs secondary to the hemorrhage.

Areas covered: The mechanisms of the delayed injury are reviewed, including angiographic vasospasm, cortical spreading ischemia, small arteriolar constriction, microthromboemboli, free radical injury and inflammation. Some current and prospective therapies for SAH are discussed, in the context of these complications. Statins have been particularly promising in experimental studies.

Expert opinion: Multiple mechanisms are involved in the pathogenesis of the delayed insult after SAH. New drugs may need to target multiple pathways to injury. Trials aiming to treat complications after SAH could benefit from taking into account the multifactorial pathogenesis of delayed insults.

Publication types

  • Review

MeSH terms

  • Animals
  • Brain Injuries / etiology
  • Brain Injuries / pathology
  • Brain Ischemia / etiology*
  • Brain Ischemia / pathology
  • Drug Design
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Intracranial Aneurysm / complications*
  • Intracranial Aneurysm / pathology
  • Intracranial Aneurysm / therapy
  • Molecular Targeted Therapy
  • Subarachnoid Hemorrhage / complications*
  • Subarachnoid Hemorrhage / pathology
  • Subarachnoid Hemorrhage / therapy
  • Time Factors

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors